diabetes
Diabetes drug holds promise to slow Parkinson’s progression
August 4, 2017Medical Communications, Research and Development Parkinson's disease, biotech, diabetes, drugs, pharma, pharmaceutical
There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …
Revealing the missing evidence: Randomised real-life studies in basal insulin therapy
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data
Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …
‘Vaccine’ to lower cholesterol enters human trials
June 20, 2017Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes
After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …
Reversal of type 1 diabetes possible through century-old vaccine
June 14, 2017Research and Development BCG, Type 1 diabetes, Vaccine, diabetes
The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …
Type 2 diabetes directly linked to BMI
June 12, 2017Research and Development, Sales and Marketing diabetes, type 2 diabetes
Research emerging from the American Diabetes Association’s meeting in San Diego has revealed that the likelihood of developing type 2 …
Strong showing for AZ asthma drug, but diabetes treatment flops
May 23, 2017Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes
AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …
FDA demands new warnings for J&J diabetes drug over amputation risk
May 17, 2017Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes
Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
Researchers control blood sugar levels in mice via smartphone app
May 2, 2017Manufacturing and Production, Research and Development diabetes
Scientists at Shanghai’s East China Normal University have been able to regulate blood sugar levels in mice via the use …
New prognostic tool accurately predicts kidney failure risk
April 19, 2017Research and Development diabetes, kidney failure
Researchers from the Joslin Diabetes Center (JDC) have developed a prognostic tool which they claim can accurately predict the risk …
New drug therapy ‘reverses’ diabetes in mice
March 29, 2017Research and Development diabetes
A team of researchers at the University of California, San Diego (UCSD) have developed a drug therapy which has shown …
Pakistan’s problem with diabetes – with 7 million diabetics
March 20, 2017Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes
Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …
Diabetes drug could be key to treating aggressive breast cancer, research suggests
March 8, 2017Research and Development Cancer, diabetes
Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
Weight loss drug reduces diabetes risk by 80%, according to ICL research
February 27, 2017Research and Development, Sales and Marketing diabetes, icl, liraglutide
Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Sanofi and Novo to face off in diabetes sphere following FDA approvals
November 22, 2016Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes
Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …
